Skip to main content
. 2015 May 11;10(5):e0126591. doi: 10.1371/journal.pone.0126591

Table 2. Univariate analysis of the association between selected clinical characteristics and 30-day mortality.

Clinical Characteristic Died
n (%) RR 95% CI p-value
All subjects 152 (18.2)
Female 77 (17.3) 0.89 0.67–1.19 0.45
Mean age (SE) 33.7 ±8.5 0.90 0.74–1.09 0.28
New diagnosis of HIV 43 (16.8) 0.89 0.65–1.23 0.48
Fevers, chills, night sweats 130 (17.7) 0.79 0.53–1.19 0.27
Weight loss (subjective) 148 (18.6) 1.76 0.69–4.51 0.21
Sputum production 140 (18.2) 1.05 0.62–1.80 0.86
Dyspnea 92 (21.1) 1.40 1.04–1.89 0.02
Wheezing 37 (18.4) 1.01 0.73–1.42 0.93
Chest pain 96 (17.8) 0.94 0.70–1.27 0.69
Smoked >99 cigarettes (lifetime) 37 (19.4) 1.08 0.78–1.51 0.63
Ever consumed alcohol 107 (19.7) 1.27 0.93–1.75 0.13
ART ≥ 30 days prior to enrollment 18 (15.8) 0.85 0.54–1.33 0.47
PCP prophylaxis ≥ 30 days prior to enrollment 65 (17.6) 0.94 0.71–1.26 0.70
Temperature <35.5°C or >38°C 68 (20.9) 1.26 0.95–1.69 0.11
Heart rate >120 beats/minute 55 (23.7) 1.47 1.10–1.98 0.01
Respiratory rate >30 breaths/minute 88 (23.3) 1.66 1.24–2.23 0.0005
Oxygen saturation <90% 43 (31.4) 2.01 1.49–2.72 <0.0001
Abnormal lung exam 101 (19.4) 1.19 0.88–1.62 0.25
CD4 cell count <50 cells/mm3 94 (22.7) 1.65 1.22–2.22 0.0008

RR, risk ratio; CI, confidence interval; SE, standard error; PCP, Pneumocystis pneumonia.